Latest Mass Tort News and Updates

Claims against AndroGel manufacturer AbbVie were rejected by the jury in Circuit Court of Cook County, Illinois; thereby, ruling in favor of the defendant. Allegations faced by AbbVie included failure to warn the plaintiff, James Couch, and his…

A Pennsylvania woman was awarded close to $57 million that included $50 million as punitive damages for injuries she suffered from the vaginal mesh devices; the lawsuit was filed against Johnson & Johnson subsidiary Ethicon Inc., it is also…

Just when hopes were running high on the fourth Xarelto trial scheduled to begin this October in the US District Court ND Texas, we are informed that it has been postponed until early 2018. The verdicts for the three previous lawsuits went in…

Judge Fallon presiding over Xarelto MDL 2592 also denied a motion for new bellwether trials for the plaintiffs who had lost to the defendants in the first two bellwethers trials. The judge stood by his decisions stating that they were made on the…

A move made this September wherein the plaintiffs involved in the pelvic mesh related injury against Boston Scientific agreed for their cases to be heard in a courtroom other than the Philadelphia Court of Common Pleas. This decision has its…

The very first bellwether trial for TRT lawsuits ended in a mistrial which involved a plaintiff whose allegation against AndroGel was that it caused his heart attack, thereby bringing a pause phase. But the $150 Million verdict to…

The number of cases filed for Risperdal, IVC Filters, Xarelto lawsuits is increasing as the days…

The Plaintiffs of Benicar MDL 2606 have been offered a settlement amount of $300 million by Daiichi Sankyo. If a 95% agreement is reached at by all the claimants, the settlement procedure will be finalized for the 2,300 cases filed under the…

Defendants named in the Risperdal gynecomastia litigation, Johnson & Johnson, and its Janssen Pharmaceuticals subsidiary, will now have to compensate thousands of Risperdal…

Last week, the U.S. Food and Drug Administration (FDA) issued a letter to Bayer indicating requirements for submitting adverse event reports and postmarket activities associated with …